Top Performing Pharma and Healthcare Mutual Funds in Last 3 Years
Top Performing Pharma and Healthcare Mutual Funds in Last 3 Years

Top Performing Pharma and Healthcare Mutual Funds in Last 3 Years

Indian pharmaceutical stocks surged 5 per cent on Thursday, defying a broader market decline, following the U.S. administration's decision to exempt pharmaceutical products from new reciprocal tariffs.

DSIJ Intelligence Article rating: 5.0

Indian pharmaceutical stocks surged 5 per cent on Thursday, defying a broader market decline, following the U.S. administration's decision to exempt pharmaceutical products from new reciprocal tariffs.

Pharma Funds : Investment Potential
Pharma Funds : Investment Potential

Pharma Funds : Investment Potential

Investors often assume that investing in the pharmaceutical sector is a safe bet given that its products and services are always in demand.

Ninad Ramdasi Article rating: 4.1

Investors often assume that investing in the pharmaceutical sector is a safe bet given that its products and services are always in demand.

Looking for exposure in the pharma sector? Here are some worthy considerations
Looking for exposure in the pharma sector? Here are some worthy considerations

Looking for exposure in the pharma sector? Here are some worthy considerations

Pharma and healthcare sector have rewarded its investors handsomely in the couple of years. In this article we would be listing pharma funds that are worth considering.

DSIJ Intelligence Article rating: 4.4

Pharma and healthcare sector have rewarded its investors handsomely in the couple of years. In this article we would be listing pharma funds that are worth considering.

DSIJ MINDSHARE

Mkt Commentary4-Apr, 2025

Penny Stocks6-Apr, 2025

Multibaggers6-Apr, 2025

Mindshare6-Apr, 2025

Swing Trading6-Apr, 2025

Knowledge

General22-Mar, 2025

MF14-Mar, 2025

MF14-Mar, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR